Twist Bioscience Corporation (TWST) has a consensus analyst rating of Buy, based on 13 analysts covering the stock. Of those, 10 recommend buying, 2 recommend holding, and 1 recommend selling.
The analyst consensus price target for TWST is $48.25, representing a -16.0% downside from the current price of $57.41. Price targets range from a low of $41.00 to a high of $52.00.
